Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Integra Lifesciences (NQ: IART )

28.89 +0.14 (+0.49%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 3, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,469,298
Open 29.40
Bid (Size) 29.10 (13)
Ask (Size) 41.85 (1)
Prev. Close 28.75
Today's Range 28.54 - 29.71
52wk Range 27.18 - 51.12
Shares Outstanding 84,579,542
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Integra Lifesciences Holdings Corp - IART
From Pomerantz LLP
Via GlobeNewswire
NASDAQ:IART is probably undervalued for the fundamentals it is displaying.
INTEGRA LIFESCIENCES HOLDING (NASDAQ:IART) is a prime example of a stock that offers more than what meets the eye in terms of fundamentals. 
Via Chartmill

Performance

YTD
-33.20%
-33.20%
1 Month
-14.78%
-14.78%
3 Month
-28.08%
-28.08%
6 Month
-25.45%
-25.45%
1 Year
-42.45%
-42.45%

More News

Read More
Top 3 Health Care Stocks That Could Lead To Your Biggest Gains In March
Via Benzinga
NASDAQ:IART, an undervalued stock with good fundamentals.
Via Chartmill
Analyst Scoreboard: 5 Ratings For Integra Lifesciences
Via Benzinga
Recap: Integra Lifesciences Q4 Earnings
Via Benzinga
The Analyst Landscape: 7 Takes On Integra Lifesciences
Via Benzinga
The Latest Analyst Ratings for Integra Lifesciences
Via Benzinga
INTEGRA ALERT: Bragar Eagel & Squire, P.C. is Investigating Integra LifeSciences Holdings Corp. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Neurosurgery Focused Integra LifeSciences Bolsters Its ENT Portfolio With $275M Acquisition Deal
Via Benzinga
Block To Rally Around 54%? Here Are 10 Top Analyst Forecasts For Tuesday
Via Benzinga
4 Analysts Have This to Say About Integra Lifesciences
Via Benzinga
INTEGRA DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Integra LifeSciences Holdings Corp. and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire, P.C.
Via Business Wire
INTEGRA LIFESCIENCES 72 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors With Losses in Excess of $100,000 of Deadline in Class Action Lawsuit Against Integra LifeSciences Holdings Corporation - IART
From Kahn Swick & Foti, LLC
Via Business Wire
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Integra LifeSciences Holdings Corporation (IART)
From The Law Offices of Frank R. Cruz
Via Business Wire
INTEGRA INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Integra To Contact Him Directly To Discuss Their Options
From Faruqi & Faruqi LLP
Via GlobeNewswire
ROSEN, A LEADING NATIONAL FIRM, Encourages Integra LifeSciences Holdings Corporation Investors with Losses in Excess of $100K to Secure Counsel Before Important November 13 Deadline in Securities Class Action - IART
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal Product Safety
INTEGRA ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Integra LifeSciences Holdings Corp. and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
IART DEADLINE ALERT: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Integra LifeSciences Holdings Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - IART
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal Product Safety
INTEGRA LIFESCIENCES HOLDINGS CORPORATION (NASDAQ: IART) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Integra LifeSciences Holdings Corporation
From Bernstein Liebhard LLP
Via GlobeNewswire
Investor Notice: Deadline on November 13, 2023 Coming Up in Lawsuit Against Integra LifeSciences Holdings Corporation (NASDAQ:IART)
Via SBWire
Topics Lawsuit
Exposures Financial Legal
ROSEN, LEADING INVESTOR COUNSEL, Encourages Integra LifeSciences Holdings Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – IART
From The Rosen Law Firm PA
Via GlobeNewswire
INTEGRA SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Integra To Contact Him Directly To Discuss Their Options
From Faruqi & Faruqi LLP
Via GlobeNewswire
INTEGRA ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Integra LifeSciences Holdings Corp. and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
ROSEN, A LEADING LAW FIRM, Encourages Integra LifeSciences Holdings Corporation Investors With Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - IART
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal Product Safety
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.